Macbeth, Fergus, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Evans, Jessica, Ahmed, Sheikh, Cohen, David, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Knoyle, Dana, Linnane, Seamus, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Moore, Barbara, Woll, Penella J., Appel, Wiebke, Dickson, Jeanette, Ferry, David, Brammer, Caroline and Griffiths, Gareth
2016.
Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial.
Journal of Clinical Oncology
34
(5)
, pp. 488-494.
10.1200/JCO.2015.64.0268
|
|
Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth
2015.
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma.
European Urology
67
(4)
, pp. 599-602.
10.1016/j.eururo.2014.11.003
|
|
|



Up a level